Health Technology Assessment (HTA)

Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.

News

Spotlight on OHE: Making Health Care Choices and Decisions

7 January 2013

OHE’s research and consulting captures a range of key issues that affect how health care systems are organised and how decisions are made within them. For…

What-Constitutes-Evidence-Rawlins-2013-LARGE
Publication

What constitutes credible evidence of effectiveness

1 June 2013

In this monograph based his remarks at the 19th OHE Annual Lecture, Professor Sir Michael Rawlins examines the standards of proof required to show the effectiveness…

Cracks through the ice on a melting glacier in Alaska
News

Spotlight on OHE: Value Based Pricing and New Technologies

31 December 2012

The OHE has been very active in conceptualising approaches incorporating a broader assessment of the elements of value (often called “value based pricing” or “VBP”), as…

Training for the data collection phase of the EQ-5D-5L Value Set for England study
News

Spotlight on OHE: Measurement and Valuation of Health Using PROMs

20 December 2012

The OHE continues to play a central role in the development and use of patient-reported outcomes measures (PROMs). The last quarter of 2012 was characteristically busy.

News

New Research by OHE and University of Glasgow on cost of QALYs in Scotland

17 December 2012

New health care technologies often improve health but also increase costs. Judging whether they are good value for money involves comparing what QALYs are gained from…

Cracks through the ice on a melting glacier in Alaska
News

New Findings: Public Attitudes Towards End-of-Life Treatment in England and Wales

7 December 2012

In 2009, the UK’s National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that…

The R&D Cost of a New Medicine
News

OHE Study on Pharmaceutical R&D Costs Released

3 December 2012

How much it costs to research and develop a successful new medicine has been an important policy issue at least since the 1960s. Cost estimates matter…

Value Based Pricing in Sweden
News

Value Based Pricing in Sweden: Lessons for Design?

28 November 2012

OHE has just published a Seminar Briefing by Ulf Persson, head of the Swedish Institute of Health Economics, which reviews experience with the Swedish value based…

Prof Tony Culyer
News

Collected Essays by Tony Culyer on Health Economics

25 November 2012

Just released is a collection of essays by Prof Tony Culyer, a founding father of health economics whose life’s work has been to bring clarity to…